Uncle Sam’s Secret Inventions: License a Health Breakthrough Today!
Published Date: 6/16/2025
Notice
Summary
The U.S. Government owns a cool new invention and is ready to share it with businesses and innovators who want to license it and bring it to market fast. This means anyone interested can jump in, help improve public health, and possibly make some money. Act quickly to grab this chance and turn government research into real-world solutions!
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Government Invention Available for Licensing
The U.S. Government owns an invention that is available for licensing so businesses and innovators can commercialize federally funded research to benefit public health. If you are a business owner or entrepreneur, you can apply to license the invention and potentially bring a product to market and earn revenue.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20151, Notice of NIH Tribal Consultations and Listening Session
The NIH is inviting Tribal leaders and members to join two important meetings and a listening session during the National Congress of American Indians Annual Convention in October 2026. They’ll talk about new health research projects, renewing support for Tribal health centers, and shaping a new Tribal Data Sovereignty Policy. Tribes can also send their thoughts by November 20, 2026, helping shape future health programs and policies.
2026-19718, Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding two closed virtual meetings in October 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists and research teams applying for grants should note these dates as they impact funding decisions but don’t involve public attendance.
2026-19804, Submission for OMB Review; 30-Day Comment Request; Generic Clearance for NIH Citizen Science and Crowdsourcing Projects (Office of the Director)
The NIH is asking for approval to keep collecting info from citizen science and crowdsourcing projects, making it easier to gather public input on health research. This affects anyone involved in these projects and invites comments by October 28, 2026. No new costs or big changes, just a smooth way to keep the data flowing for better science!
2026-19719, Center for Scientific Review; Amended Notice of Meeting
The NIH’s Center for Scientific Review is shortening a key meeting from two days to just one day on October 13, 2026, keeping the same 9 a.m. to 6 p.m. hours. This change affects members of the Surgical Sciences and Bioengineering review group and means less time in the room but no public access. No money changes or delays are expected—just a quicker, tighter meeting!
2026-19706, Draft NIH Policy on Sharing Summary Level Study Results With Clinical Research Participants
The NIH wants to make it easier for people who join clinical studies to get simple summaries of the study results. This new policy aims to boost trust and teamwork between researchers and participants, helping science move faster and better. They’re asking for your thoughts by October 26, 2026, so get ready to share your ideas!
2026-19431, Government-Owned Inventions; Availability for Licensing
The government is offering a new invention for licensing that makes stem cell transplants safer and less harsh, especially for leukemia patients and older folks. This tech uses a special protein to prepare patients for transplants without the tough side effects of chemo and radiation. Companies can start licensing this preclinical innovation now to help bring better treatments to market faster.
Previous / Next Documents
Previous: 2025-10853, Information Collection Being Reviewed by the Federal Communications Commission
The FCC is asking the public and other agencies to help review and improve its paperwork to make it easier and less time-consuming. This affects anyone who fills out FCC forms, especially small businesses with fewer than 25 employees. They want your feedback now to keep things clear, useful, and fair—so get ready to share your thoughts before the deadline!
Next: 2025-10855, Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Biologic License Application (BLA) 761440 for Belantamab Mafodotin
The FDA is holding a public meeting to talk about a new cancer drug called Belantamab Mafodotin. They want advice from experts and feedback from the public before deciding if the drug should be approved. This could affect patients and doctors soon, so everyone’s input matters!